Novartis (NVS) Debt/EBITDA US GAAP (year values) |
|||||||||
2021 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
Debt/EBITDA | 0.08 | 0.08 | 0.55 | 0.55 | 0.67 | 0.93 | |||
Changes by years, y/y, % | -95% | 0% | +559% | 0% | +22% | -2.0% |
Novartis. Debt/EBITDA
Novartis. Debt/EBITDA, changes, %
Novartis (NVS) Debt/EBITDA US GAAP (quarter values) |
||||||||
2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
Debt/EBITDA | 0.99 | 0.96 | 0.67 | 0.66 | 0.93 | 0.93 | ||
Changes by years, y/y, % | +162% | +171% | +122% | +19% | -6% | |||
Changes by quarters, q/q, % | +80% | -3% | -30% | -2% | +42% |